chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 2.0
Sex: F
Vaccine: FLU3, HIBV, PNC13, FLU3, HIBV, PNC13
Symptoms: Febrile convulsion, Musculoskeletal stiffness, Pyrexia, Vaccine positive rechallenge, Vomiting
Clinical narrative: Fever, febrile seizure lasted for 3-5 minutes; body stiffness, eyes rolled to sides.
Age: 2.0
Sex: F
Vaccine: FLU3, HIBV, PNC13, FLU3, HIBV, PNC13
Symptoms: Febrile convulsion, Gaze palsy, Musculoskeletal stiffness, Pyrexia
Clinical narrative: Fever, febrile seizure lasted for 3-5 minutes; body stiffness, eyes rolled to sides.
Age: 88.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: 5 x 5 inch reddened, hot area at injection site.
Age: 37.0
Sex: F
Vaccine: HEPAB, RAB, YF
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient states that the day after yellow fever administration the site became "red, swollen, and itchy". Denies other symptoms. Denies any treatment. On 3/1/2012, the assessed area was red approximately 1 inch in diameter. Pt reports occassional itching. Denies other symptoms.
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Grand mal convulsion
Clinical narrative: Ten days after patient got vaccine started getting grand mal seizures and since then has still been getting them.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Pruritus, Urticaria
Clinical narrative: Went to ER for hives 48 hrs after vaccine.  Followed up office, still had hives, started on prednisone, ranitidine & loratadine, continue BENADRYL q 6 hrs PRN increased itching.
Age: 60.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Inflammation, Pain, Pruritus, Swelling
Clinical narrative: 2/23/12 pt had pain & inflammation, area 4 cm x 4 cm red & raised, pt went to PCP 2/24/12, antibiotic KEFLEX 500 mg QID & BROLENE ointment. 2/24/12 itching noted.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site haematoma, Injection site inflammation
Clinical narrative: Injection R/upper thigh inflamed with hematoma.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash erythematous
Clinical narrative: Red spots on torso and legs x 1day.
Age: 0.55
Sex: M
Vaccine: DTAPIPVHIB, FLU3, PNC13
Symptoms: Pyrexia
Clinical narrative: Febrile episode 104.4 on 3/6/12 10:45 am. 101.1 on 3/5/12 1600 H/ 102.0 3/6/12 early am.
Age: 10.0
Sex: M
Vaccine: UNK
Symptoms: Injection site erythema
Clinical narrative: Redness on injection site like mosquito bite size.
Age: 67.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site urticaria, Injection site warmth
Clinical narrative: Redness, fever, hives to 6-8 inch diameter area to injection site & upper arm (right).
Age: 1.26
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Injection site erythema, Injection site warmth, Pyrexia
Clinical narrative: Fever up to 102.3 degrees taken with temporal thermometer. Left leg hot & red in area vaccine given.
Age: 0.65
Sex: M
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Parent noted rash that developed after his last Flu vaccine.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Loss of consciousness
Clinical narrative: Patient passed out while checking out at reception area. Checked patient's vitals and placed in room to lie down. Recovered well.
Age: 47.0
Sex: F
Vaccine: FLU3, HEP
Symptoms: Erythema, Oedema peripheral, Pruritus
Clinical narrative: Pink, raised, itching section of arm that was 6" long, 2" wide lasted about a week. Seem to flare up in the evenings. No treatment, stop itching on its own.
Age: 22.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Discomfort, Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Lt arm reddened, painful with edema of arm.  Increasing discomfort and redness.  Seen by physician on 03/05/2012 with a dx of cellulitis. Prescribed ABT, Hydrocortisone Cr, with Benadryl prn for itching.  Improved on 03/07/2012.
Age: 22.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus
Clinical narrative: Lt arm reddened, painful with edema of arm.  Increasing discomfort and redness.  Seen by physician on 03/05/2012 with a dx of cellulitis. Prescribed ABT, Hydrocortisone Cr, with Benadryl prn for itching.  Improved on 03/07/2012.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Rash pruritic
Clinical narrative: Pruritic rash on trunk x 24-36 hrs.
Age: 35.0
Sex: M
Vaccine: HEP
Symptoms: Expired drug administered
Clinical narrative: Vaccinated with expired vaccine.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Computerised tomogram normal, Hypoaesthesia, Injection site nodule, Injection site pain, Malaise
Clinical narrative: Tingling and pain at site, numbness in arm, general malaise, bump at site.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: Tingling and pain at site, numbness in arm, general malaise, bump at site.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza, Influenza A virus test positive
Clinical narrative: Contracted Influenza A Infection.
Age: 41.0
Sex: F
Vaccine: HEPA, TDAP
Symptoms: Arthralgia, Dizziness, Dyspnoea, Injection site pain, Muscular weakness
Clinical narrative: Muscle weakness, joint soreness, difficulty breathing, light headed.
Age: 0.74
Sex: F
Vaccine: DT
Symptoms: Crying, Electroencephalogram normal, Hypopnoea, Lethargy, Pallor
Clinical narrative: Vaccine given at 9am. Pt. cried all night and awoke at 5:30am with an episode of pallor, shallow breathing and lethargy similar to the episode after the 2mos vaccines.
Age: 0.16
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV1
Symptoms: Crying, Decreased eye contact
Clinical narrative: Inconsolable crying for 3 days after 2 month vaccinations (Pentacel, Prevnar, Hepatitis B #1 and Rotavirus). Also less interactive per parents.
Age: 1.02
Sex: F
Vaccine: MMR, PNC13, VARCEL
Symptoms: Blister, Induration, Local reaction, Rash, Scar
Clinical narrative: Local reaction, rash -> swelling - blister after about 10 day. Scar depressed "like chicken pox usually do" with hard border (by father's description).
Age: 1.02
Sex: F
Vaccine: MMR, PNC13, VARCEL
Symptoms: Swelling
Clinical narrative: Local reaction, rash -> swelling - blister after about 10 day. Scar depressed "like chicken pox usually do" with hard border (by father's description).
Age: 51.0
Sex: M
Vaccine: TDAP
Symptoms: Dyspnoea, Palpitations, Tachycardia, Tremor, Wheezing
Clinical narrative: Shortness of Breath, Wheezing, Palpitations, Tachycardia, Wheezing, Tremors.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Herpes zoster, Paraesthesia
Clinical narrative: Shingles above right eye with tingling and burning to the area.
Age: 70.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Herpes zoster
Clinical narrative: Shingles to left side of face with involvement of left eye with 5th cranial nerve distribution.
Age: 0.18
Sex: F
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Erythema, Injection site pain, Injection site swelling, Irritability, Restlessness
Clinical narrative: Within 4 hours she developed localized erythema, swelling and apparent pain in the right thigh, extending up to the inguinal crease and down to the knee. She was unsettled and fussy, but had no generalized rash, no vomiting or respiratory distress. She had no known fever, but was treated with several doses of Tylenol.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Antinuclear antibody positive, Fatigue, Immunology test abnormal, Laboratory test abnormal
Clinical narrative: I just kept getting sicker and sicker after the shot.  I ended up starting to miss work a few weeks following the shot, was out of work entirely by mid-November, and missed work for five months.  Was diagnosed with chronic fatigue in December of 2008.  I'm still not well.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise, Viral titre increased
Clinical narrative: I just kept getting sicker and sicker after the shot.  I ended up starting to miss work a few weeks following the shot, was out of work entirely by mid-November, and missed work for five months.  Was diagnosed with chronic fatigue in December of 2008.  I'm still not well.
Age: 1.66
Sex: F
Vaccine: DTAP, MMR
Symptoms: Urticaria
Clinical narrative: Urticaria.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Burning sensation, Wrong drug administered
Clinical narrative: PT RECIEVE IMPROPER VACCINE DUE TO FAILURE OF ADMINISTRATOR. PROPER VERIFICATIONS WERE DONE. PT FELT BURNING SENSATION 11:13. WRONG MED IDENTIFIED. PROVIDER AND PREVENTATIVE MED TECH. INSTRUCTED ADMINISTRATOR ON PROTOCOLS AND PROCEDURES. PT FELT LITTLE TO NO SIDE-EFFECTS AFTER 30:00 MINUTES AND WAS RELEASED UNDER PERSONAL CARE WITH INSTRUCTIONS ON TEDIOUS OBSERVATION FOR NEXT 72HRS. ANY ISSUES PT WAS INSTRUCTED TO NEAREST MEDICAL FACILITY A.S.A.P.
Age: 1.72
Sex: F
Vaccine: DTAPHEPBIP, PNC13
Symptoms: Balance disorder, Fall, Gait disturbance, Muscular weakness, Pain in extremity
Clinical narrative: Severe pain in right leg, limping on leg, weakness in leg, off balance, having to hold on to wall/table/chair to hold herself up, falling down because she cannot hold herself up.
Age: 12.0
Sex: M
Vaccine: MEN
Symptoms: Injection site swelling
Clinical narrative: Significant swelling in the arm in the area where the vaccine shot was administered.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Erythema, Feeling hot, Induration
Clinical narrative: 13x5 cm area erythema with warmth & induration.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Balance disorder, Blood test normal, CSF test normal, Computerised tomogram normal, Gait disturbance
Clinical narrative: 4 days post vaccine patient developed status migrainosus; subsequent muscle rigidity, visual disturbance, balance/gait disturbance, diffuse muscle pain.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Muscle rigidity, Myalgia, Nuclear magnetic resonance imaging normal, Status migrainosus, Visual impairment
Clinical narrative: 4 days post vaccine patient developed status migrainosus; subsequent muscle rigidity, visual disturbance, balance/gait disturbance, diffuse muscle pain.
Age: 5.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Hypersensitivity, Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: 2/27/12 - pt. seen in office. ? Cellulitis ? allergic reaction 9cm x 9cm, erythema with lesions near center at injection site. Warm, swollen. Pt given KEFLEX 250 - 1 tsp. TID x 7D.
Age: 5.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Skin lesion
Clinical narrative: 2/27/12 - pt. seen in office. ? Cellulitis ? allergic reaction 9cm x 9cm, erythema with lesions near center at injection site. Warm, swollen. Pt given KEFLEX 250 - 1 tsp. TID x 7D.
Age: 0.18
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Crying
Clinical narrative: Crying inconsolably 6pm - 11pm. Only stopped for breath & for 20 minutes at 9pm (during bath) & again at 10pm (during bath). Mother request VAERS documentation.
Age: 0.48
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Abdominal distension, Abdominal pain
Clinical narrative: Abdominal pain & distention intermittent.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Swelling
Clinical narrative: Patient noticed swelling on his trunk below the armpit - slightly painful - a day or 2 after receiving ZOSTAVAX.
Age: 1.46
Sex: M
Vaccine: DTAP, DTAPIPVHIB, FLU3
Symptoms: Abasia, Body temperature fluctuation, Body temperature increased, Chest X-ray normal, Cyanosis
Clinical narrative: See online report.
Age: 1.46
Sex: M
Vaccine: DTAP, DTAPIPVHIB, FLU3
Symptoms: Diet refusal, Full blood count normal, Hypersomnia, Hypophagia, Injection site swelling
Clinical narrative: See online report.
Age: 1.46
Sex: M
Vaccine: DTAP, DTAPIPVHIB, FLU3
Symptoms: Skin discolouration, Tremor, Urine analysis normal
Clinical narrative: See online report.
Age: 1.46
Sex: M
Vaccine: DTAP, DTAPIPVHIB, FLU3
Symptoms: Unevaluable event
Clinical narrative: See online report.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL, HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Day #2 RA at Varicella admin. site turned "red" - raised slightly - warm to touch - abt size of 50 cent piece - Mom is a RN - admin. TYLENOL & compresses. No other symptoms reported.
Age: 31.0
Sex: M
Vaccine: TDAP
Symptoms: Feeling hot, Induration, Oedema, Tenderness
Clinical narrative: Initial induration, tenderness - 48 hours marked induration, erythema, warmth & superficial edema.
Sex: F
Vaccine: HPV4
Symptoms: Coma
Clinical narrative: Information has been received from a talk radio show, concerning a female patient, who on unknown date was vaccinated with the dose of GARDASIL (dose, route and lot# not reported). It was reported that on unknown date the patient went into coma's after receiving therapy on GARDASIL. The patient's outcome was unknown at the time of report. It was unknown if the patient sought medical attention. Upon internal review, coma was determined to be an other important medical event. Attempts are being made to verify the existence of an identifiable patient and reporter. This is one of several report received from the same source. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, PPV, VARCEL
Symptoms: Erythema, Injection site reaction, Local reaction, Skin lesion, Type III immune complex mediated reaction
Clinical narrative: Local reaction right arm. Erythematous wheal like lesion 2 x 1.5 inches and 2 other lesions 1" x 1" HPV Varicella. Arthus Phenomenon.
Age: 18.0
Sex: F
Vaccine: HEPA, PPV, VARCEL
Symptoms: Urticaria
Clinical narrative: Local reaction right arm. Erythematous wheal like lesion 2 x 1.5 inches and 2 other lesions 1" x 1" HPV Varicella. Arthus Phenomenon.
Age: 71.0
Sex: U
Vaccine: VARZOS
Symptoms: Erythema, Pain in extremity
Clinical narrative: Got shingles shot on 2/24/12. The next day my arm was red and sore and the day after it spread it was red and sore almost to my elbow I slept with ice which they did not tell me to use but I talked to my Dr. & he said to use ice. It took almost a week for it to go away.
Age: 1.26
Sex: F
Vaccine: DTAPIPVHIB, MMR
Symptoms: Rash erythematous, Rash macular
Clinical narrative: Pt developed rash on abdomen on 2-24-12. On 2-25-12 rash was described as red blotchy and was worse over body mostly on face and trunk. Temp was 98.1 no fever and no signs of itching. Pt finished AMOXIL 1 week prior to rash for B/L otitis media (prescribed on 2/9/12).
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Immediate post-injection reaction, Injection site pain
Clinical narrative: Immediately following vaccine, patient reported burning at the injection site that felt like it travelled up her right arm (where she received the vaccine), up through her neck and behind her ear. She reported feeling fine about an hour later.
Age: 18.0
Sex: M
Vaccine: HEPA, HPV4, TDAP, VARCEL, HEPA, HPV4, TDAP, VARCEL
Symptoms: Injection site erythema, Pruritus
Clinical narrative: Redness at injection site size of 50 cent piece. Itching, no induration. Ibuprofen, apply ice locally to area.
Age: 0.36
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Crying
Clinical narrative: Mom reported that child cried for 5 hours after vaccine was given.
Age: 2.0
Sex: M
Vaccine: FLUX, HEPA
Symptoms: Gianotti-Crosti syndrome, Rash erythematous, Rash papular
Clinical narrative: This literature report concerns a 2-year-old male. His medical history was unremarkable. On an unknown date the patient received influenza vaccine (brand unspecified) and hepatitis A vaccine. The patient presented with a two week history of an asymptomatic cutaneous eruption involving his arms, legs and cheeks. Physical exam revealed monomorphous erythematous papules distributed over his extremities and cheeks with  sparing of the palms, soles and trunk. Review of systems was negative except for hepatitis A and influenza vaccination 10 days prior to the onset of the eruption. His parents declined a biopsy. Given the temporal sequence of events and lack of any other relevant precipitant, a clinical diagnosis of Gianotti-Crosti syndrome (GCS) was made. Because GCS is usually a self-limited eruption, and in this case asymptomatic, the patient and his family were given reassurance and the rash resolved over the course of 6 weeks. Reporter comments: The authors concluded that this case represented a rarely reported instance of GCS associated with hepatitis A and influenza vaccination. Their findings reinforce the link between highly immunogenic vaccines, such was hepatitis A, and GCS. To the best of their knowledge, only one other case of GCS in association with influenza vaccine has been published in 1995 [non CSL vaccine]. A number of other immunizations have been implicated as a cause of GCS, such as hepatitis B, measles and polio.
Age: 0.16
Sex: M
Vaccine: HIBV, PNC13, RV1
Symptoms: Cyanosis, Tremor
Clinical narrative: Mother reports that after vaccines pt awoke from a nap & lips were blue, pt shaking. Reports symptoms resolved quickly. Reported to provider on 2/28/2012.
Age: 0.35
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Death, Respiratory arrest
Clinical narrative: Patient received her 4 month vaccines (PENTACEL - (DTaP-Hib-IPV), PREVNAR 13 (pneumococcal 13 Conj) and Rotavirus oral vaccine) on 1/12/12 around 12 noon. On 1/13/12 at 1022 our office received a call from Dad stating patient stopped breathing at daycare, 911 called. At 1652 on 1/13/12 the coroner called to report her death.
Age: 0.38
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Rash
Clinical narrative: Bumpy rash starting on face and spreading to face.  Bumpy rash on legs only at 2 month vaccines given 9-20-2011.
Age: 46.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Injection site swelling, Urticaria
Clinical narrative: Pt reports hives covering chest, back and neck. Painful swelling in arm where administered.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dizziness, Eye swelling, Headache, Pain
Clinical narrative: About 3PM shot given (on 2/21/2012). About 8PM - Adverse event headache, eyes swell, aches, stuffy nose, dizzy, tight throat, chills.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Throat tightness
Clinical narrative: About 3PM shot given (on 2/21/2012). About 8PM - Adverse event headache, eyes swell, aches, stuffy nose, dizzy, tight throat, chills.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Feeling hot, Pruritus, Rash
Clinical narrative: Normal ZOSTAVAX rash occurred on Friday & Saturday. On Sunday, patient noticed it feeling hot, burning, & itching. When using ZYRTEC & Hydrocortisone Crm. didn't make it feel better, she phoned the pharmacy Monday. We instructed her to go to her MD. MD gave her prednisone taper & Cephalexin 500 mg QID.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site macule, Injection site vesicles, Oedema peripheral, Pruritus
Clinical narrative: 24 hours after Tdap, developed two pinpoint sized red macules & few pinpoint sized vesicles around injection site. Slight lateral deltoid edema. Was itchy. Resolved in 24 hours.
Age: 62.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Pain, Rash vesicular
Clinical narrative: Classic zosteriform rash, painful, unilateral, along T6-T7 dermatome, started within 3 days of receipt of ZOSTAVAX & Influenza vaccine.
Age: 1.46
Sex: F
Vaccine: DTAP, HEPA, HIBV, PNC13
Symptoms: Seizure like phenomena, Staring
Clinical narrative: Had an stared episode while having breakfast. Taken to ER. Unsure if fever with seizure like episode.
Age: 24.0
Sex: F
Vaccine: HEPA, TYP
Symptoms: Arthropathy
Clinical narrative: Received vaccine on 2/9/12, and presented to clinic on 2/20/12 with c/o noting a "feeling" in right arm & shoulder beginning 2/18/12, shoulder droop noted 2/19/12. Returned to orthopedic & treated with steroids & NSAIDS.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Dyspnoea, Rash pruritic, Wheezing
Clinical narrative: Pruritic rash on trunk and difficulty breathing & wheezing. Administered BENADRYL and nebulized XOPENEX. Rash improved & breathing improved prior to leaving clinic. Occurred within 30 minutes of administration.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Lethargy
Clinical narrative: Pt came in and had redness, swelling at injection site also said she felt "a little lethargic". Instructed pt to call MD but she felt it wasn't serious enough for MD visit but wanting to report injection site reaction.
Age: 22.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Insomnia, Pain in extremity
Clinical narrative: Injection site and arm hurt for 3 days following Tdap vaccine.  Then stopped for 2 days and now is hurting so bad patient is unable to sleep at night.
Age: 15.0
Sex: M
Vaccine: FLU3, HPV4
Symptoms: Dizziness, Muscle spasms, Syncope
Clinical narrative: Fainted, Dizziness, awkward spasms of arms and legs for about an hour.
Age: 0.51
Sex: F
Vaccine: DTAPIPVHIB, FLU3, HEP, PNC13, RV5
Symptoms: Body temperature increased, Ear infection, Hypersensitivity, Nasopharyngitis, Urticaria
Clinical narrative: Phone call from mom on 03/06/2012 reporting that patient started with a temp. the day after she rec'ed vaccines on 03/01/2012-temp. was 102F, gave her fever reducer-mom reports that the temp. went up to 102.2F-monitored her and the temp. was normal the next day.  On Sunday 03/04/2012-mom reports that patient started with a cold and ear infection and on 03/06/2012 she broke out with hives on the back of her head, back and thighs-mom took her to the dr. on 03/06/2012 and was informed by the dr. that patient was having an allergic reaction to the vaccines she rec'ed on 03/01/2012.  Mom reports that the dr. only started her on an allergy med. (Atarax 10/5 1/2 teaspoon 3 times a day) due to the hives-may start an antibiotic later.
Age: 22.0
Sex: M
Vaccine: HEP
Symptoms: Flank pain, Injection site pain
Clinical narrative: PAIN TO INJECTION SITE RADIATING THROUGHOUT RIGHT SIDE TO A DEGREE THAT CAUSED THE PATIENT TO VISIT A LOCAL EMERGENCY ROOM.
Age: 1.01
Sex: F
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Pyrexia, Vomiting
Clinical narrative: Per mother fever, vomiting. Advised acetaminophen or ibuprofen, bland diet, po fluids and close monitoring. Later that day fever of 105.1 reported advised ER.
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Induration, Injection site erythema, Injection site pain, Pain
Clinical narrative: Site L deltoid area, soreness, then developed red area, pain with ROM of arm. 3/6/12, induration 4.5cm,  3/9/12 red warm area 10cm x 14 cm.  Rash on left side of neck.
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Rash, Skin warm
Clinical narrative: Site L deltoid area, soreness, then developed red area, pain with ROM of arm. 3/6/12, induration 4.5cm,  3/9/12 red warm area 10cm x 14 cm.  Rash on left side of neck.
Age: 1.01
Sex: M
Vaccine: PPV, VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site swelling
Clinical narrative: After 9-10 days, he developed a red raised lump. The area stayed red for about 1 week. It was the same place were he received his varicella vaccine.
Age: 24.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Erythema, Malaise, Pain, Pyrexia
Clinical narrative: Pt. states she experienced onset of fever, redness, soreness and general malaise. Reported to Clinic on 3/7/2012 with continued redness, soreness, on arm where TDAP was given. Fever was resolved aprox. 24 hrs. after injection.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Oedema peripheral, Pruritus
Clinical narrative: Swelling to upper arm from elbow to shoulder, redness and itchy feeling. Administered Tylenol & cold pack compression which only helped a little.
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Rash, Rash erythematous, Rash papular
Clinical narrative: Rash arms - back itching chest - neck - body fine papular, erythematous, pruritis.
Age: 4.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Erythema
Clinical narrative: Large 2cm x 4cm area of erythema to Rt thigh.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Oedema
Clinical narrative: 6 cm area of erythema, mild edema.
Age: 0.19
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Intussusception
Clinical narrative: Intussusception.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Diarrhoea, Headache, Pain
Clinical narrative: Severe headaches, diarrhea interfering with function, b/w pain T 98.1 degrees.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Within 48 hours, the child developed pain, erythema, & localized soft tissue swelling at the injection, advised MOTRIN & BENADRYL prn.
Age: 4.0
Sex: F
Vaccine: DTAP, FLU3, IPV, MMRV
Symptoms: Injection site erythema
Clinical narrative: (L) arm redness 8 cm x 9 1/2 cm.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Headache, Injection site reaction, Nausea
Clinical narrative: Severe sudden diarrhea, nausea.  Subsequently developed headache, reaction at injection site.
Age: 66.0
Sex: M
Vaccine: TDAP
Symptoms: Dizziness, Motion sickness
Clinical narrative: Patient c/o dizziness, motion sickness- BP was normal and symptoms lessened a few hours later but still lingered 2 days later.
Age: 34.0
Sex: M
Vaccine: ANTH, TDAP, TYP
Symptoms: Arthralgia, Muscular weakness, Pyrexia
Clinical narrative: Patient stated he had a fever as high as 101.0 for about 18 hours. Severe incapacitaing joint pain in shoulders, elbows, lower back, and knees. Unable to make a fist.
Age: 1.38
Sex: F
Vaccine: VARCEL
Symptoms: Convulsion, Full blood count, Metabolic function test, Pyrexia, Urine analysis
Clinical narrative: Vomiting followed by fever followed by seizure.
Age: 1.38
Sex: F
Vaccine: VARCEL
Symptoms: Vomiting
Clinical narrative: Vomiting followed by fever followed by seizure.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Fatigue, Feeling hot, Oedema peripheral, Respiration abnormal
Clinical narrative: Heavy breathing, feeling tired. Went home to bed. Next morning went to work and arm felt hot. After 9-hour shift went home, taking off shirt found left arm to be extremely swollen, hot and red. The red was appearing in her arm as if you poured something on it and it was running down unevenly - like streaking I assume. She then took Benadryl and it took approximately 4 days to resolve. Did not report to CPH, doctor, or anyone outside the home. Patient came in today with a friend to get his MCV4 and happened to mention the side effects to me. I then asked further questions, it had not been reported, so I am completing a VAERS today, 03/08/2012.
Age: 33.0
Sex: F
Vaccine: ANTH, TYP
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: The patient reported to the Site with swelling, redness and pain in her Left Arm.  The redness covered an area of 16 cm long by 8 cm wide. (Info from SF 600).
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Pain, Skin warm
Clinical narrative: Large localized area of redness half-way between shoulder and elbow.  Warm to touch, very sore.
Age: 0.19
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Diarrhoea
Clinical narrative: Diarrhea for 1 month following vaccinations.
Age: 1.36
Sex: F
Vaccine: DTAP, FLU3, HEPA, HIBV
Symptoms: Injection site erythema, Injection site haematoma, Injection site oedema, Local reaction, Vaccination complication
Clinical narrative: Lt. thigh with redness & edema about 9-10 cm. No induration; afebrile; slight bruise. Dx at OV = Local reaction to vaccine. Tx = observe; ice - prn; call office if s/s increase.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema
Clinical narrative: 4 1/2 cm x 4 1/2 cm reaction to (L) thigh, redness. BENADRYL and KEFLEX were given.
Age: 32.0
Sex: F
Vaccine: HEP
Symptoms: Convulsion
Clinical narrative: Information has been received from a pharmacist (Pharm. D. ) and a 32 year old female patient who received doses of RECOMBIVAX HB in 2004. The second dose was vaccinated on approximately 21-AUG-2004 (dose, route and lot# not reported). Concomitant therapy included LAMICTAL. On 31-AUG-2004 (one and a half weeks later) the patient began to experience seizures that continue to the present time. She averaged one to two seizures a month and she was currently on medication for her seizures. Complete medical worked up. She sought unspecified medical attention. At the time of reporting, the patient had not recovered from seizures. Upon internal review, the seizure was determined to be an other important medical event. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: HEP
Symptoms: Hepatitis B antibody negative
Clinical narrative: Information has been received from an approximately 34 year old registered nurse reporting on herself who in approximately 2004 experienced had a history of Muscular weakness, asthenia, convulsion, dyspnoea, watery eyes, almost psychosis, eye disorder, fatigue. fibromyalgia, joint stiffness, eyes tearing, Lyme disease, nausea, nervous system disorder, pain, vomiting and weight increased after received of MMR (WAES0810USA01168). In 2008 she was vaccinated with a the series of RECOMBIVAX HB (manufacturer unknown) (lot number, dose and site of administration were not reported). On an unspecified date in 2008, after the series the patient's titer was negative. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3
Symptoms: Allergy to chemicals, Allergy to metals, Injection site swelling, Injection site vesicles, Skin test positive
Clinical narrative: Initial report was received from a health care professional on 03 June 2011. A male patient who was five years old at the time of the event, had received on 14 September 2009 a fifth dose intramuscular right deltoid injection of DAPTACEL, lot number C3000AA and nasal FLUMIST (lot number not reported) and the day after vaccination experienced swelling in the entire "left" deltoid. The patient was evaluated by an allergist and was determined to have allergies to aluminum and glutaraldehyde. Treatments and concomitant medications were not reported. No further information was available at the time of the report. The patient's outcome was not reported. Follow-up information was received from a health care professional on 18 July 2011 who also reported to it to VAERS (VAERS report number: 372006). The patient had received DAPTACEL and FLUMIST, lot number 500709P (also reported as 509709P) on 14 September 2009 at 11:55 AM and two days after vaccination on 16 September 2009 (previously reported as the day after vaccination), the patient experienced blisters, erythema and edema at the vaccination site. The edema and blistering progressed over a period of hours. Treatments included BENADRYL, MOTRIN, ORAPRED, TOPICORT and BACTROBAN. Diagnostic tests included allergy patch testing that revealed a strong positive reaction to aluminum and a positive to glutaraldehyde. The patient had a history of allergic rhinitis, allergies to dog dander, cat dander, tree nuts, lobster, trees, ragweed, weeds and grasses. He had an anaphylactic allergy to walnuts and had an allergic reaction to the Varicella vaccine 16 days after it was administered, 25 September 2008. The patient's symptoms improved two days after start of treatment. No further information was available at the time of the report. The patient's outcome was reported as recovered. The reporter for this case is the same as for case 2011-03222. Documents held by sender: none.
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3
Symptoms: Vaccination site erythema, Vaccination site oedema
Clinical narrative: Initial report was received from a health care professional on 03 June 2011. A male patient who was five years old at the time of the event, had received on 14 September 2009 a fifth dose intramuscular right deltoid injection of DAPTACEL, lot number C3000AA and nasal FLUMIST (lot number not reported) and the day after vaccination experienced swelling in the entire "left" deltoid. The patient was evaluated by an allergist and was determined to have allergies to aluminum and glutaraldehyde. Treatments and concomitant medications were not reported. No further information was available at the time of the report. The patient's outcome was not reported. Follow-up information was received from a health care professional on 18 July 2011 who also reported to it to VAERS (VAERS report number: 372006). The patient had received DAPTACEL and FLUMIST, lot number 500709P (also reported as 509709P) on 14 September 2009 at 11:55 AM and two days after vaccination on 16 September 2009 (previously reported as the day after vaccination), the patient experienced blisters, erythema and edema at the vaccination site. The edema and blistering progressed over a period of hours. Treatments included BENADRYL, MOTRIN, ORAPRED, TOPICORT and BACTROBAN. Diagnostic tests included allergy patch testing that revealed a strong positive reaction to aluminum and a positive to glutaraldehyde. The patient had a history of allergic rhinitis, allergies to dog dander, cat dander, tree nuts, lobster, trees, ragweed, weeds and grasses. He had an anaphylactic allergy to walnuts and had an allergic reaction to the Varicella vaccine 16 days after it was administered, 25 September 2008. The patient's symptoms improved two days after start of treatment. No further information was available at the time of the report. The patient's outcome was reported as recovered. The reporter for this case is the same as for case 2011-03222. Documents held by sender: none.
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Anaphylactic reaction, Lethargy, Pallor, Pharyngeal oedema, Urticaria
Clinical narrative: This case was retrieved from the VAERS database on 20 June 2011, under reference number (VAERS ID 393564). A female patient with a reported age of 2 (months or years were not reported) and a history of FPIES (Food Protein-Induced Enterocolitis Syndrome) and food allergies (egg, milk, soy, shellfish, peanut, tree nut, chicken, peas, turkey), had received on 23 July 2010 an intramuscular third dose right leg injection of DAPTACEL, lot number C3358A, an intramuscular third dose right leg injection of ACTHIB, lot number UH125AB (sanofi pasteur SA lot number E0836-1) and an intramuscular first dose left leg injection of PREVNAR 13 (Pfizer/Wyeth lot number E49135) and within 10 minutes experienced anaphylaxis. She developed urticaria, pallor, lethargy, throat swelling and wheezing. She was treated with epinephrine, prednisone, BENADRYL and XOPENEX in the office. The patient was transferred to the ER (emergency room) and treated with another course of epi (epinephrine) and IV (intravenous) SOLUMEDROL. The patient was hospitalized (dates not reported). Concomitant medications included desonide, ATARAX and SINGULAIR. Lab data and current illnesses were reported as none. No further information was provided at the time of the report. The patient's outcome was reported as recovered (date not reported). Documents held by sender: none.
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Wheezing
Clinical narrative: This case was retrieved from the VAERS database on 20 June 2011, under reference number (VAERS ID 393564). A female patient with a reported age of 2 (months or years were not reported) and a history of FPIES (Food Protein-Induced Enterocolitis Syndrome) and food allergies (egg, milk, soy, shellfish, peanut, tree nut, chicken, peas, turkey), had received on 23 July 2010 an intramuscular third dose right leg injection of DAPTACEL, lot number C3358A, an intramuscular third dose right leg injection of ACTHIB, lot number UH125AB (sanofi pasteur SA lot number E0836-1) and an intramuscular first dose left leg injection of PREVNAR 13 (Pfizer/Wyeth lot number E49135) and within 10 minutes experienced anaphylaxis. She developed urticaria, pallor, lethargy, throat swelling and wheezing. She was treated with epinephrine, prednisone, BENADRYL and XOPENEX in the office. The patient was transferred to the ER (emergency room) and treated with another course of epi (epinephrine) and IV (intravenous) SOLUMEDROL. The patient was hospitalized (dates not reported). Concomitant medications included desonide, ATARAX and SINGULAIR. Lab data and current illnesses were reported as none. No further information was provided at the time of the report. The patient's outcome was reported as recovered (date not reported). Documents held by sender: none.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Convulsion, Lethargy
Clinical narrative: Initial report received from a health care professional on 26 January 2011, under temporary VAERS e-report number E-51550. A 17-year-old female patient received an intramuscular left deltoid injection of MENACTRA (lot number U3355BA) on 18 January 2011, and an injection of DECAVAC (lot number reported as 3059, not a complete sanofi pasteur lot number) on 07 January 2011. Three days pot-vaccination with MENACTRA, on 21 January 2011, the patient experienced a seizure. According to the reporter, the patient had previously experienced seizures 3 days post-vaccination following her first and second doses of GARDASIL (lot not reported). Human papillomavirus vaccine had been administered in February 2012, and the patient had been taking anti-seizure medication that time. The patient was scheduled for an EEG, and was following up with a neurologist due to ongoing complaints of lethargy. Per the reporter, the patient "may be having small seizures". The event of seizure was reported to be recovered, although the patient continued to have ongoing lethargy. Follow-up information was received from a health care professional on 29 March 2011. The complete lot number for DECAVAC was reported as U3059AA (previously reported as 3059). The patient was treated with VIMPAT (spelled VINPAT) 100 mg two times a day since February 2011. According to the reporter, the patient was diagnosed with seizure disorder in 2007. She was on medication to control seizures until 2009. The patient was reported to be seizure free until the first HPV (human papillomavirus vaccine) was administered in February 0f 2010. She experienced multiple seizures three days after administration of HPV #1, HPV #2 and MENACTRA. The seizures were not witnessed by the health care provider and the patient was referred to a neurologist and is scheduled for the visit in late March. According to the reporter the "patient seems to be less lethargic". No further information was available at the time of the report. Documents held by sender: None.
Age: 68.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal pain, Colonoscopy normal, Computerised tomogram abnormal, Diarrhoea, Flatulence
Clinical narrative: Information has been received from a physician concerning a female patient who 0n 22-JAN-2011 was vaccinated with the first dose of RECOMBIVAX HB (lot # not reported). After receiving the first dose, the patient had diarrhea but it resolved on an unspecified date. On 19-FEB-2011, the patient was vaccinated with a second dose of RECOMBIVAX HB (lot # not reported). However, after she had the second dose, she developed another episode and still had diarrhea. At the time of the report, the patient had not recovered. It was reported that the physician combined 2 pediatric doses (0.5 ml) to make 1 ml adult dose because the adult formulation was not available. The patient sought unspecified medical attention. Follow-up information was received from the physician indicating that the 68 year and 2 month old female with CELEBREX and PERCOCET allergies and postmenopausal vasomotor symptoms and a history of cholecystectomy in 2004 who on 22-JAN-2011 was vaccinated IM in right arm with the first 1ml dose of RECOMBIVAX HB (lot # 666809/1316Z, thimerosal-free) and on 19-FEB-2011 was vaccinated IM in left arm with the second dose of RECOMBIVAX HB (lot # 668309/1317Z, thimerosal-free). Suspect second therapy included the first 1ml dose of hepatitis A (lot # 668912/1087Z) IM in left arm on 22-JAN-2011. On approximately 23-JAN-2011 the patient experienced intermittent and persistent episodes of bowel movements (as many as 5 per day, all soft, some loose, preceded by abdominal cramping and gas) with began within 24 hour after receiving 2 vaccines. On 24-FEB-2011 the patient experienced severe, persistent diarrhea (as many as 7 episodes in a 10-hour period, as well as during the night, associated with abdominal cramping and pain). The diarrhea still persisted as of this date, despite anti-motility agents. The patient has lost 7 lbs. Colonoscopy was performed on 1-MAR-2011 for GI evaluation and the result was unremarkable per patient's report. Bloodwork was performed and the result was elevated liver enzymes. Liver CT was performed and the result was some ductal enlargement. The patient was scheduled for another GI evaluation on 4-APR-2011. At the time of the report, the patient had not recovered. No further information is available.
Age: 68.0
Sex: F
Vaccine: HEP
Symptoms: Frequent bowel movements, Hepatic enzyme increased, Hepatomegaly, Liver function test abnormal, Vaccine positive rechallenge
Clinical narrative: Information has been received from a physician concerning a female patient who 0n 22-JAN-2011 was vaccinated with the first dose of RECOMBIVAX HB (lot # not reported). After receiving the first dose, the patient had diarrhea but it resolved on an unspecified date. On 19-FEB-2011, the patient was vaccinated with a second dose of RECOMBIVAX HB (lot # not reported). However, after she had the second dose, she developed another episode and still had diarrhea. At the time of the report, the patient had not recovered. It was reported that the physician combined 2 pediatric doses (0.5 ml) to make 1 ml adult dose because the adult formulation was not available. The patient sought unspecified medical attention. Follow-up information was received from the physician indicating that the 68 year and 2 month old female with CELEBREX and PERCOCET allergies and postmenopausal vasomotor symptoms and a history of cholecystectomy in 2004 who on 22-JAN-2011 was vaccinated IM in right arm with the first 1ml dose of RECOMBIVAX HB (lot # 666809/1316Z, thimerosal-free) and on 19-FEB-2011 was vaccinated IM in left arm with the second dose of RECOMBIVAX HB (lot # 668309/1317Z, thimerosal-free). Suspect second therapy included the first 1ml dose of hepatitis A (lot # 668912/1087Z) IM in left arm on 22-JAN-2011. On approximately 23-JAN-2011 the patient experienced intermittent and persistent episodes of bowel movements (as many as 5 per day, all soft, some loose, preceded by abdominal cramping and gas) with began within 24 hour after receiving 2 vaccines. On 24-FEB-2011 the patient experienced severe, persistent diarrhea (as many as 7 episodes in a 10-hour period, as well as during the night, associated with abdominal cramping and pain). The diarrhea still persisted as of this date, despite anti-motility agents. The patient has lost 7 lbs. Colonoscopy was performed on 1-MAR-2011 for GI evaluation and the result was unremarkable per patient's report. Bloodwork was performed and the result was elevated liver enzymes. Liver CT was performed and the result was some ductal enlargement. The patient was scheduled for another GI evaluation on 4-APR-2011. At the time of the report, the patient had not recovered. No further information is available.
Age: 68.0
Sex: F
Vaccine: HEP
Symptoms: Weight decreased
Clinical narrative: Information has been received from a physician concerning a female patient who 0n 22-JAN-2011 was vaccinated with the first dose of RECOMBIVAX HB (lot # not reported). After receiving the first dose, the patient had diarrhea but it resolved on an unspecified date. On 19-FEB-2011, the patient was vaccinated with a second dose of RECOMBIVAX HB (lot # not reported). However, after she had the second dose, she developed another episode and still had diarrhea. At the time of the report, the patient had not recovered. It was reported that the physician combined 2 pediatric doses (0.5 ml) to make 1 ml adult dose because the adult formulation was not available. The patient sought unspecified medical attention. Follow-up information was received from the physician indicating that the 68 year and 2 month old female with CELEBREX and PERCOCET allergies and postmenopausal vasomotor symptoms and a history of cholecystectomy in 2004 who on 22-JAN-2011 was vaccinated IM in right arm with the first 1ml dose of RECOMBIVAX HB (lot # 666809/1316Z, thimerosal-free) and on 19-FEB-2011 was vaccinated IM in left arm with the second dose of RECOMBIVAX HB (lot # 668309/1317Z, thimerosal-free). Suspect second therapy included the first 1ml dose of hepatitis A (lot # 668912/1087Z) IM in left arm on 22-JAN-2011. On approximately 23-JAN-2011 the patient experienced intermittent and persistent episodes of bowel movements (as many as 5 per day, all soft, some loose, preceded by abdominal cramping and gas) with began within 24 hour after receiving 2 vaccines. On 24-FEB-2011 the patient experienced severe, persistent diarrhea (as many as 7 episodes in a 10-hour period, as well as during the night, associated with abdominal cramping and pain). The diarrhea still persisted as of this date, despite anti-motility agents. The patient has lost 7 lbs. Colonoscopy was performed on 1-MAR-2011 for GI evaluation and the result was unremarkable per patient's report. Bloodwork was performed and the result was elevated liver enzymes. Liver CT was performed and the result was some ductal enlargement. The patient was scheduled for another GI evaluation on 4-APR-2011. At the time of the report, the patient had not recovered. No further information is available.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Full blood count normal, Mononucleosis heterophile test negative, Nasal congestion, Oropharyngeal pain, Otitis media
Clinical narrative: Initial report received from a nurse on 21 June 2011. A 12-year-old male patient had received a dose of VARIVAX (Merck, lot number not reported), and a dose of Hep A vaccine (manufacturer unknown, lot number not reported) on 09 June 2011. The patient subsequently received a dose of ADACEL (lot number U3956AA, Sanofi Pasteur lot number C3902), and MENACTRA (lot number U3051AA) in the right thigh on 20 June 2011. On 21 June 2011, one day following the ADACEL and MENACTRA vaccinations, which was also 12 days following varicella and Hep A vaccinations, the patient experienced temporal temperature of 105.0 degrees Fahrenheit with no other symptoms. The event required a physician visit, however it was not reported whether the patient required treatment. At the time of ADACEL and MENACTRA vaccinations, it was noted the patient had no known allergies, no concurrent illnesses, but was thought to be taking other medication of anastrozol ("ARIMIDEX" (indication not reported)). Outcome was reported as not recovered. Follow-up information was received on 02 August 2011 from a health care professional. The patient had a history of precocious puberty, an allergy to LUPRON and at the time of vaccination had nasal congestion. The patient had received the varicella vaccine, lot number 1697Z in the right thigh and HAVRIX, GSK lot number AHAVB498BB in the left thigh. According to the reporter, the patient's mother called to report the patient developed nasal congestion and a sore throat the day after the vaccines were administered (nasal congestion was also reported to be present at the time of vaccination). The patient was evaluated by the physician on 24 June 2011 and was diagnosed with otitis media. Treatments included TYLENOL, MOTRIN, OMNICEF and popsicles. Laboratory investigations included a CBC, Mono and strep test which were all negative. No further information was available at the time of the report. The patient's outcome was not reported. Follow-up information was received from a health care professional on 06 September 2011. On 24 June 2011, the patient's fever resolved. The patient has had no adverse reactions reported since that time. The outcome was reported as recovered on 24 June 2011. Documents held by sender: None.